Genesis Therapeutics logo

Genesis Therapeutics Inc.

Biotechnology

Genesis Therapeutics Stock

Genesis Therapeutics is a biotechnology company pioneering the use of artificial intelligence (AI) for drug discovery and development. Its proprietary platform, GEMS (Genesis Exploration of Molecular Space), employs cutting-edge AI models for predicting molecular properties, designing novel drug candidates, and optimizing existing leads.

Management Team

Evan Feinberg, Ph.D. Co-Founder and CEO
Ben Sklaroff Co-Founder and CTO
Will McCarthy COO
Peppi Prasit, Ph.D. Acting CSO

Funding Information